McCullough Keith P, Morgenstern Hal, Rayner Hugh C, Port Friedrich K, Jadoul Michel Y, Akizawa Tadao, Pisoni Ronald L, Herman William H, Robinson Bruce M
Arbor Research Collaborative for Health, Ann Arbor, Michigan.
Department of Epidemiology, Ann Arbor, Michigan; Department of Environmental Health Sciences, School of Public Health, Ann Arbor, Michigan; Department of Urology, Ann Arbor, Michigan.
Am J Kidney Dis. 2025 Jan;85(1):25-35.e1. doi: 10.1053/j.ajkd.2024.06.017. Epub 2024 Aug 9.
RATIONALE & OBJECTIVE: Case-mix adjusted hemodialysis mortality has decreased since 1998. Many factors that influence mortality may have contributed to this trend, and these associations may differ by continental region. We studied changes in hemodialysis facility practices over time and their potential role in mediating changes in patient survival.
Observational prospective cohort study.
SETTING & PARTICIPANTS: Adult hemodialysis patients treated in 500 hemodialysis facilities participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS) between 1999 and 2015 in the United States, Japan, and 4 European countries: Germany, Italy, Spain, and the United Kingdom.
Four practice measures at each facility: the percentages of patients with Kt/V≥1.2, interdialytic weight gain [IDWG]<5.7%, phosphorus<6mg/dL, and using arteriovenous fistulas (AVFs).
Patient survival.
Mediation analyses, adjusted for case mix, were conducted using 3-year study phase as the exposure and facility practice measures as potential mediators.
In Europe, we observed a 13% improvement in overall case-mix adjusted survival per decade. Trends in facility practice measures, especially Kt/V and phosphorus, explained 10% improvement in case-mix survival per decade, representing 77% (10% explained of 13% improvement) of the observed improvement. In Japan, 73% of the observed 12%/decade improvement in case-mix adjusted survival could be attributed to facility practices, especially Kt/V and IDWG. In the United States, 56% of the observed 47%/decade improvement in case-mix adjusted survival could be attributed to facility practices, especially AVF use and phosphorus control.
Unmeasured changes in the characteristics of the patient population over this period may confound the observed associations.
The improvements in adjusted hemodialysis patient survival in Europe, Japan, and the United States from 1999 to 2015 can be largely explained by improvements in specific facility practices. Future changes in patient survival may be responsive to further evolution in the implementation of common clinical practices.
PLAIN-LANGUAGE SUMMARY: Case-mix adjusted survival of patients treated with hemodialysis has improved over the last 2 decades in the United States, Japan, and Europe. Some of this improvement can be explained by region-specific changes in 4 dialysis practices, namely increases in the proportions of patients achieving (1) Kt/V≥1.2, (2) serum phosphorus levels<6mg/dL, (3) interdialytic weight gain<5.7% of body weight, and/or (4) use of arteriovenous fistulas as vascular access, with the magnitude varying according to region-specific trends in these practices. These findings suggest that further improvement in these practice measures may be attended by further reductions in mortality among patients treated with maintenance hemodialysis.
自1998年以来,病例组合调整后的血液透析死亡率有所下降。许多影响死亡率的因素可能导致了这一趋势,并且这些关联可能因大陆地区而异。我们研究了血液透析机构的实践随时间的变化及其在介导患者生存变化中的潜在作用。
观察性前瞻性队列研究。
1999年至2015年间在美国、日本以及4个欧洲国家(德国、意大利、西班牙和英国)的500家参与透析结果和实践模式研究(DOPPS)的血液透析机构接受治疗的成年血液透析患者。
每个机构的四项实践指标:Kt/V≥1.2的患者百分比、透析间期体重增加[IDWG]<5.7%、血磷<6mg/dL以及使用动静脉内瘘(AVF)。
患者生存情况。
使用3年研究阶段作为暴露因素,机构实践指标作为潜在中介因素,进行病例组合调整后的中介分析。
在欧洲,我们观察到每十年总体病例组合调整后的生存率提高了13%。机构实践指标的趋势,尤其是Kt/V和血磷,解释了每十年病例组合生存率提高的10%,占观察到的改善的77%(13%的改善中10%得到解释)。在日本,观察到的病例组合调整后生存率每十年提高12%,其中73%可归因于机构实践,尤其是Kt/V和IDWG。在美国,观察到的病例组合调整后生存率每十年提高47%,其中56%可归因于机构实践,尤其是AVF的使用和血磷控制。
在此期间患者人群特征的未测量变化可能会混淆观察到的关联。
1999年至2015年期间,欧洲、日本和美国血液透析患者调整后生存率的提高在很大程度上可以通过特定机构实践的改善来解释